U.S. market Closed. Opens in 1 hour 59 minutes

NGNE | Neurogene Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue3.26M3.20M2.28M1.82M340.00K
Gross Profit-3.26M-3.20M-2.28M-1.82M-340.00K
Operating Expenses55.58M56.52M50.53M39.73M24.10M
Selling, General & Admin11.19M9.01M8.27M15.39M17.79M
Research & Development44.39M47.51M42.26M24.34M6.32M
Other Operating Expenses-28.00K-7.00KN/AN/AN/A
Operating Income-55.58M-56.52M-50.53M-41.55M-24.44M
Other Expenses / Income16.33M-7.00K17.00K8.28M-45.00M
Before Tax Income-36.32M-55.19M-50.52M-33.28M-69.44M
Income Tax Expenses-16.00K-5.00K17.00K-1.00168.14K
Net Income-36.32M-55.19M-50.52M-33.28M-69.44M
Interest Expenses12.00K2.00KN/AN/A1.00K
Basic Shares Outstanding12.82M12.82M55.04M51.83M27.03M
Diluted Shares Outstanding12.82M12.82M55.04M51.83M27.03M
EBITDA-49.36M-51.99M-49.57M-39.73M-24.10M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-36.32M-55.19M-50.50M-33.28M-69.27M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙